Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
63.6M
-
Shares change
-
+880K
-
Total reported value, excl. options
-
$2.8B
-
Value change
-
+$37.3M
-
Put/Call ratio
-
1.3
-
Number of buys
-
96
-
Number of sells
-
-123
-
Price
-
$44.05
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q1 2014
257 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q1 2014.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.6M shares
of 71.9M outstanding shares and own 88.43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.54M shares), Neuberger Berman Group LLC (5.41M shares), FRANKLIN RESOURCES INC (4.44M shares), BlackRock Fund Advisors (3.9M shares), State Street Corp (2.74M shares), BlackRock Institutional Trust Company, N.A. (2.01M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.98M shares), KALMAR INVESTMENTS INC /DE/ (1.96M shares), BAMCO INC /NY/ (1.82M shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.69M shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.